Medicared For All Logo

Mayur Patel MD in Burbank, California

Home California Burbank

Mayur Patel MD has Pulmonary Disease as his primary medical specialty. Their primary office is: 2625 W Alameda Ave in Burbank, California. They attended Sorry, his university is not listed and graduated in 1988 (around 36 years of experience). They are listed as doing telehealth appointments.


Mayur C Patel MD Office Phone and Directions

Mayur Patel MD
2625 W Alameda Ave
Burbank, California 91505
818-843-5864


Patient Ratings
Please rate your experience with Mayur Patel MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 818-843-5864


Enter a starting address:


Healthcare Info for Mayur Patel MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1988
The Primary Medical Specialty for Mayur Patel MD is listed as: Pulmonary Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 36
PAC (PECOS ID)#: 7719932920
NPI #: 1669451571
NPI Created On: 01/10/2006
NPI Last Updated Listed as: 09/21/2007
Primary Taxonomy Code: 207RP1001X
License Number:
A056296
Listed Gender: Male

Procedures, Services, Charges


Services and Procedures include:

  1. Irrigation and suction of lung airways to obtain cells using an endoscope
  2. Removal of fluid from chest cavity with imaging guidance
  3. Insertion of needle into vein for collection of blood sample
  4. Pneumococcal vaccine for injection into muscle
  5. Vaccine for influenza for administration into muscle, 0.5 ml dosage
  6. Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older
  7. Routine ekg using at least 12 leads including interpretation and report
  8. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
  9. Measurement of largest amount of air breathed in an out of lungs over one minute
  10. Test for exercise-induced lung stress
  11. Respiratory inhaled pressure or nonpressure treatment to relieve airway obstruction or for sputum specimen
  12. Determination of lung volumes using gas dilution or washout
  13. Measurement of lung diffusing capacity
  14. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  15. New patient office or other outpatient visit, typically 30 minutes
  16. Established patient office or other outpatient visit, typically 15 minutes
  17. Established patient office or other outpatient, visit typically 25 minutes
  18. Established patient office or other outpatient, visit typically 40 minutes
  19. Initial hospital inpatient care, typically 50 minutes per day
  20. Initial hospital inpatient care, typically 70 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788540217

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: UPTRAVI

Open Associated Drug #1: 66215-602-14

Drug or Biological: Drug

Product Category #2: Cardiology

Name Of Drug #2:: OPSUMIT

Associated Drug #2: 66215-501-30


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788540219

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: UPTRAVI

Open Associated Drug #1: 66215-602-14

Drug or Biological: Drug

Product Category #2: Cardiology

Name Of Drug #2:: OPSUMIT

Associated Drug #2: 66215-501-30


Payments Total: $2

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801600507

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $4

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801978651

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $5

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802361775

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $5

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802459173

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $6

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802562891

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802702513

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802804127

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $4

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802885053

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Pulmonary Disease Professionals in Burbank

201 S Buena Vista St
Burbank, CA
Consultants For Lung Diseases Medical Group Inc

201 S Buena Vista St
Burbank, CA

201 S Buena Vista St
Burbank, CA
Consultants For Lung Diseases Medical Group Inc

201 S Buena Vista St
Burbank, CA
Consultants For Lung Diseases Medical Group Inc

201 S Buena Vista St
Burbank, CA
Consultants For Lung Diseases Medical Group Inc

2625 W Alameda Ave
Burbank, CA
The Regents Of The University Of California

Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry